Additional file 1. Table 1. Database search strategy
PubMed Search
((("osteoporosis, postmenopausal"[MeSH Terms] OR ("osteoporosis"[All Fields] AND "postmenopausal"[All Fields]) OR "postmenopausal osteoporosis"[All Fields] OR "osteoporosis"[All Fields] OR "osteoporosis"[MeSH Terms]) OR "osteopenia"[All Fields]) AND ((((("exercise"[MeSH Terms] OR "exercise"[All Fields]) OR (("exercise"[MeSH Terms] OR "exercise"[All Fields]) AND ("education"[Subheading] OR "education"[All Fields] OR "training"[All Fields] OR "education"[MeSH Terms] OR "training"[All Fields]))) OR ("exercise therapy"[MeSH Terms] OR "exercise therapy"[All Fields])) OR ("resistance training"[MeSH Terms] OR "resistance training"[All Fields])) OR "aquatic exercise"[All Fields])) AND ((((((("activities of daily living"[MeSH Terms] OR "activities of daily living"[All Fields]) OR "functional tasks"[All Fields]) OR "physical function"[All Fields]) OR "dual tasking"[All Fields]) OR "self-perceived function"[All Fields]) OR "self-reported physical function"[All Fields]) OR "avoidance of activities"[All Fields])
CINAHL search
S1 / (MH "Osteoporosis+") OR "osteoporosis" / Display
S2 / "osteopenia" / Display
S3 / S1 OR S2 / Display
S4 / (MH "Exercise+") OR "exercise" OR (MH "Therapeutic Exercise") OR (MH "Resistance Training") OR (MH "Aquatic Exercises") OR (MH “ Strength Training”) OR (MH “Aerobic Training”) OR (MH “weight bearing”) / Display
S5 / (MH "Activities of Daily Living+") OR "activities of daily living" / Display
S6 / (MH "Bone Density") OR "bone mass" / Display
S7 / "bone density" / Display
S8 / (MH "Quality of Life+") OR "quality of life" / Display
S9 / S5 OR S6 OR S7 OR S8 / Display
S10 / S3 AND S4 AND / 714
Note. The same strategy in CINAHL used for MBASE and SPORTDiscus.

Additional file 1.Table 2.

Evaluation of Quality of an Intervention Study

This form is used to extract relevant data on effectiveness from your study and to rate the quality of the published study (for item interpretation see guide)

Citation: ______

Authors: ______

Title: ______

Reviewer: ______Date: ______

Patient Characteristics (age, sex, disorder, co-morbidity/important co-variates)

1.______

2.______

Sample Size ______

Interventions(Describe type, timing, frequency, equipment, provider, progression etc.)

1.______

2.______

Outcome Measures(Type and when evaluated)

Primary:______

Secondary:______

Results:

Outcomes (absolute change, significance)

Primary: ______

Secondary:______

Describe any any effect mediators (things that altered the outcomes achieved.

______

Describe any complications or adverse events that were reported

______

Evaluation of Study Design

Evaluation Criteria / Score
Study question / 2 / 1 / 0
1. Was there relevant and sufficient background work cited that led to a clear research question?
Study design
2. Was a comparison group used?
3. Was patient status at more than 1 time point considered?
4. Was data collection performed prospectively?
5. Were patients randomized to groups?
6. Was allocation concealed?
7. Were patients blinded to the extent possible?
8. Were treatment providers blinded to the extent possible?
9. Was an independent evaluator used to administer outcome measures?
Subjects
10. Did sampling procedures minimize sample/selection biases?
11. Were inclusion/exclusion criteria defined?
12. Was an appropriate enrollment obtained?
13. Was appropriate retention/follow-up obtained?
Intervention
14. Was the intervention applied according to established principles?
15. Were biases due to the treatment provider minimized (i.e. attention, training)?
16. Was the intervention compared to an appropriate comparator?
Outcomes
17. Was an appropriate primary outcome defined?
18. Were appropriate secondary outcomes considered?
19. Was an appropriate follow-up period incorporated?
Analysis
20. Was an appropriate statistical test(s) performed to indicate differences related to the intervention?
21. Was it established that the study had significant power to identify treatment effects?
22. Was the the size and clinical importance of the treatment group differences reported?
23. Were missing data accounted for and considered in analyses?
24. Were treatment benefits, adverse events and costs/implementation considerations addressed?
Recommendations
25. Were the conclusions/clinical recommendations supported by the study objectives, analysis and results?
Total Quality Score (Sum of above) =
The total score can be reported out of 100% -- total sum/25 x 100%

© Joy MacDermid 2013

Notes:

Additional file 1. Table 3. Quality appraisal

Items / ?* / Study Design / Subjects / Intervention / Outcomes / Analysis / R / T / Q%
Study / 1 / 2 / 3 / 4 / 5 / 6 / 7 / 8 / 9 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20 / 21 / 22 / 23 / 24 / 25
Alp 2009 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 2 / 1 / 0 / 2 / 2 / 1 / 2 / 1 / 1 / 1 / 2 / 0 / 0 / 2 / 0 / 1 / 33 / 66%
Angin 2015 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 0 / 1 / 2 / 2 / 2 / 1 / 1 / 2 / 1 / 1 / 1 / 2 / 2 / 2 / 2 / 0 / 1 / 35 / 70%
Arnold 2008 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 2 / 2 / 2 / 1 / 2 / 1 / 2 / 1 / 1 / 1 / 2 / 2 / 2 / 2 / 1 / 1 / 39 / 78%
Basat 2013 / 1 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 0 / 2 / 2 / 0 / 1 / 2 / 0 / 2 / 1 / 1 / 1 / 2 / 0 / 0 / 0 / 0 / 1 / 27 / 54%
Bennell 2010 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 2 / 2 / 2 / 0 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 0 / 2 / 2 / 1 / 1 / 39 / 78%
Bergland 2011 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 2 / 2 / 2 / 1 / 1 / 43 / 86%
Borba-Pinheiro 2016 / 1 / 2 / 2 / 1 / 1 / 1 / 1 / 1 / 0 / 2 / 2 / 2 / 1 / 2 / 0 / 2 / 1 / 1 / 1 / 2 / 2 / 2 / 0 / 0 / 1 / 31 / 62%
Bravo 1996 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 1 / 2 / 2 / 1 / 1 / 1 / 2 / 1 / 1 / 1 / 2 / 1 / 1 / 2 / 0 / 1 / 35 / 70%
Chien 2005 / 1 / 2 / 2 / 1 / 1 / 1 / 1 / 1 / 2 / 2 / 1 / 0 / 1 / 1 / 1 / 2 / 1 / 1 / 1 / 1 / 0 / 0 / 2 / 2 / 1 / 29 / 58%
Chyu 2010 / 2 / 2 / 2 / 1 / 1 / 2 / 1 / 1 / 2 / 2 / 2 / 1 / 1 / 2 / 1 / 2 / 1 / 1 / 1 / 2 / 0 / 1 / 0 / 1 / 1 / 33 / 66%
Devereux 2005 / 1 / 2 / 2 / 2 / 0 / 2 / 1 / 1 / 0 / 0 / 2 / 2 / 1 / 2 / 1 / 2 / 1 / 1 / 1 / 2 / 2 / 2 / 2 / 0 / 1 / 33 / 66%
Evstigneeva 2016 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 2 / 2 / 2 / 2 / 1 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 1 / 0 / 1 / 1 / 1 / 38 / 76%
Fleisher 2011 / 1 / 2 / 2 / 2 / 1 / 2 / 1 / 1 / 0 / 2 / 2 / 0 / 1 / 2 / 0 / 2 / 1 / 1 / 1 / 2 / 1 / 0 / 2 / 0 / 1 / 30 / 60%
Gianoudis 2014 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 2 / 1 / 2 / 1 / 1 / 42 / 84%
Gold 2004 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 2 / 2 / 1 / 1 / 1 / 2 / 2 / 1 / 2 / 1 / 1 / 43 / 86%
Halvarsson 2014 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 2 / 2 / 0 / 1 / 1 / 2 / 1 / 1 / 1 / 2 / 1 / 1 / 2 / 0 / 1 / 35 / 70%
Hongo 2007 / 1 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 0 / 2 / 2 / 2 / 2 / 1 / 1 / 2 / 1 / 1 / 1 / 2 / 1 / 1 / 1 / 1 / 1 / 33 / 66%
Kanemaru 2010 / 1 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 0 / 0 / 2 / 0 / 1 / 0 / 0 / 2 / 1 / 1 / 1 / 2 / 1 / 0 / 1 / 1 / 1 / 25 / 50%
Kronhed 2009 / 2 / 2 / 2 / 2 / 1 / 2 / 1 / 1 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 2 / 1 / 1 / 1 / 2 / 0 / 1 / 1 / 1 / 1 / 36 / 72%
Maciaszek 2012 / 1 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 0 / 0 / 2 / 0 / 0 / 2 / 0 / 2 / 1 / 1 / 1 / 0 / 0 / 0 / 1 / 1 / 1 / 23 / 46%
Madureira 2010 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 2 / 1 / 2 / 2 / 2 / 2 / 1 / 2 / 1 / 1 / 1 / 1 / 0 / 0 / 0 / 2 / 1 / 33 / 66%
Marchese 2012 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 0 / 1 / 2 / 0 / 2 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 0 / 0 / 1 / 1 / 1 / 28 / 56%
Nelson 1994 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 1 / 1 / 2 / 0 / 2 / 1 / 1 / 2 / 1 / 1 / 1 / 2 / 0 / 0 / 2 / 1 / 1 / 31 / 62%
Papaioannou 2003 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 2 / 2 / 2 / 0 / 1 / 1 / 2 / 2 / 1 / 1 / 1 / 2 / 0 / 1 / 2 / 0 / 1 / 33 / 66%
Smulders 2010 / 2 / 2 / 2 / 2 / 1 / 2 / 1 / 1 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 2 / 1 / 2 / 1 / 1 / 41 / 82%
Teixeira 2010 / 2 / 2 / 2 / 2 / 2 / 2 / 1 / 1 / 2 / 2 / 2 / 0 / 1 / 2 / 2 / 2 / 1 / 1 / 1 / 2 / 0 / 1 / 1 / 1 / 1 / 36 / 72%
Tolomio 2010 / 1 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 2 / 2 / 2 / 0 / 1 / 1 / 2 / 2 / 1 / 1 / 1 / 2 / 0 / 1 / 1 / 1 / 1 / 32 / 64%
Wayne 2012 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 2 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 1 / 30 / 60%
?* Research question; R Recommendation; T Total score